Volume : 11, Issue : 11, November – 2024
Title:
A REVIEW ON DRUG REPURPOSING
Authors :
J.Suma, B. Swapna, M. Gurava Reddy, Prof. Dr. K. Venugopal
Abstract :
Drug repurposing is a promising approach to identify new therapeutic uses for existing drugs, potentially speeding up the process of drug development by bypassing early stages of preclinical testing. Drug repurposing holds the potential to bring medications with known safety profiles and pharmacological properties of existing compounds, reducing the time and cost required to bring treatments to market. Recent advances in bioinformatics, computational biology, and machine learning have expanded the potential of drug repurposing, allowing researchers to mine vast datasets for drug-disease relationships and molecular targets. Methodologies behind drug repurposing, including in silico methods, high-throughput screening, and network pharmacology, as well as successful case studies where repurposed drugs have been approved for new indications. Drug repurposing represents a vital avenue in drug discovery, offering innovative solutions to unmet medical needs and facilitating more efficient therapeutic development. For example, mifepristone, an anti-progesterone medication initially prescribed for abortion, showed promise in treating psychotic depression in experiments.
Keywords: Drug Repurposing, Drug Screening, Target-Based repurposing, Artificial intelligence, Drug developments, Therapeutic innovative, Safety monitor, Clinical studies.
Cite This Article:
Please cite this article in press J.Suma et al A Review On Drug Repurposing..,Indo Am. J. P. Sci, 2024; 11 (11).
Number of Downloads : 10
References:
1. M. Simsek Finding hidden treasures in old drugs: the challenges and importance of licensing generics Drug Discovery. Today (2018).
2. Oprea, T.I. and Mestres. J., AAPS J., 2012, vol. 14, pp. 759–763. https://doi.org/10.1208/s12248-012-9390-1.
3. W.W. Fleuren et al. Application of text mining in the biomedical domain Methods (2015)
4. Chong CR, Sullivan DJ Jr. New uses for old drugs. Nature. 2007; 448 (7154):654-644
5. Moreira S, Gemayel Z, Karey S, Lamare M. Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature. Journal of Market Access & Health Policy. 2013; 1:21131.
6. Namasivayam V., Palaniappan S., Vanangamudi M. Repurposing drugs targeting epidemic viruses. Drug Discovery Today. 2022 Doi: 10.1016/j.drudis.2022.04.008. Apr 12: S1359-6446(22)00155-6. [DOI]
7. S. Salentin, M.F. Adasme, J.C. Heinrich, V.J. Haupt, S. Daminelli, Y. Zhang, M. Schroeder from malaria to cancer: computational drug repositioning of amodiaquine using PLIP interaction patterns Sci. Rep., 7 (2017), p. 11401.
8. Ebada, M.E. Drug repurposing may generate novel approaches to treating depression. J. Pharm. Pharmacol .2017,69, 1428–1436.
9. Shukla, R.; Henkel, N.D.; Alganem, K.; Hamoud, A.-r.; Reigle, J.; Alnafisah, R.S.; Eby, H.M.; Imami, A.S.; Creeden, J.F.; Miruzzi, S.A.; et al. Signature-based approaches foinformed drug repurposing: Targeting CNS disorders. Neuropsychopharmacology2021,46, 116–130
10. Xue, H.; Li, J.; Xie, H.; Wang, Y. Review of Drug Repositioning Approaches and Resources. Int. J. Biol. Sci.2018,14, 1232–124
11. Caban, A.; Pisarczyk, K.; Kopacz, K.; Kapu´sniak, A.; Toumi, M.; Rémuzat, C.; Kornfeld, A. Filling the gap in CNS drug development: Evaluation of the role of drug repurposing. J. Mark. Access Health Policy 2017,5, 1299833.
12. H. Xue, H. Li and Y. Wang, Int. J. Biol. Sci., 14, 1232– 1244 (2018).
13. Feed Forward Neural Network Definition | DeepAI. https://deepai.org/machine-learning-glossary-and-terms/feed forward-neural-network
14. Abbruzzese C., Matteoni S., Signore M., Cardone L, Nath K., Glickson J.D., Paggi M.G. J. Exp. Clin. Cancer Res. 2017; 36:169. Doi: 10.1186/s13046-017-0642-x.
15. Jin G., Wong S.T.C. Drug Discovery Today. 2014; 19:637–644. Doi: 10.1016/j.drudis.2013.11.005.
16. March-Vila E., Pinzi L., Sturm N., Tinivella A., Engkvist O., Chen H., Rastelli G. Front. Pharmocol. 2017; 8:298. doi: 10.3389/fphar.2017.00298.
17. Doman TN, McGovern SL, Witherbee BJ, Kasten TP, Kurumbail R, Stallings WC, et al. Molecular docking, and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem. 2002; 45:2213–2221.
18. Jadamba E, Shin M. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network. BioMed Res Int. 2016; 2016:7147039. DOI: 10.1155/2016/7147039.
19. Jin G, Fu C, Zhao H, Cui K, Chang J, Wong ST. A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Res 2012; 72:33-44. doi: 10.1158/0008-5472.CAN-11-2333.
20. Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med 2011; 3:96ra76. doi: 10.1126/sci-translmed.3002648.
21. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. 2006. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:(5795):1929–35.
22. Xu H, Aldrich MC, Chen Q, Liu H, Peterson NB, Dai Q, et al. Validating drug repurposing signals using electronic health records: A case study of metformin associated with reduced cancer mortality. J Am Med Inform Assoc. 2015; 22:179–191. DOI: 10.1136/amiajnl-2014-002649.
23. Samimi, N.; Farjam, M.; Klionsky, D.J.; Rezaei, N. The role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types. Autophagy 2021, 1–4.
24. Hua Y et al. Drug repositioning: Progress and challenges in drug discovery for various diseases. European Journal of Medicinal Chemistry. 2022; 234:114239
25. Jarada TN, Rokne JG, Alhajj R. A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions. Journal of Cheminformatics. 2020;12(1):1-23
26. Turanli B, et al. Drug repositioning for effective prostate cancer treatment. Frontiers in Physiology. 2018; 9:500
27. Ekins S et al. In silico repositioning of approved drugs for rare and neglected diseases. Drug Discovery Today. 2011;16(7-8):298-310
28. Sun W, Sanderson PE, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discovery Today. 2016;21(7):1189-1195.